Tranexamic Acid

Form: Oral & Injectable

Strength: Oral Tablets: 250 mg, 500 mg, 650 mg & (IV) Injection::100 mg/mL

Reference Brands: Lysteda, Cyklokapron®, Transamin®,

Category: Anemia

Tranexamic Acid is a widely used antifibrinolytic agent available for B2B pharmaceutical supply across the US and EU. Indicated for the treatment and prevention of excessive bleeding, including heavy menstrual bleeding, surgical hemorrhage, and trauma-related blood loss, Tranexamic Acid helps stabilize clots by inhibiting plasminogen activation. Offered in both oral (500 mg tablets) and injectable (100 mg/mL) forms, it is ideal for hospitals, clinics, and gynecology practices. Regulatory-compliant and GMP-certified, Tranexamic Acid ensures high demand across markets focused on bleeding control and pre-operative care. B2B partners benefit from reliable sourcing and strong market demand in both acute and chronic care settings.